Uptravi tablets 0.2mg from Nippon Shinyaku contain selexipag, a medication utilized in the treatment of pulmonary arterial hypertension (PAH) (YJ code: 2190037F1020, standard: 0.2 mg 1 tablet).
Uptravi tablets 0.2mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
